Clin Asst Prof Eugene Wong Yu Jun

About

Dr Eugene Wong is a Consultant with the Department of Gastroenterology and Hepatology at Changi General Hospital (CGH). He graduated from the Faculty of Medicine, National University of Malaysia in 2010 before obtaining his Master of Medicine (Internal Medicine) from the National University of Singapore in 2013. Dr Wong was the Chief Resident for Internal Medicine Residency (SingHealth) from 2014 to 2015 and completed his Senior Residency in Gastroenterology in 2018. 

Dr Wong has a strong passion for improving patient care through clinical research. He has published extensively in peer-reviewed journals and won numerous awards for his research works, including the prestigious Early Career Investigator Award in Clinical/Translational Science by the American Association of the Study of Liver Disease (AASLD) in 2022, and the Healthcare Disparity Award by the AASLD Foundation in 2023. He completed his Master of Clinical Investigator (MCI) in 2021 and was awarded the Nurturing Clinician Scientist Scheme by the Joint Office of Academic Medicine, SingHealth in 2020.

As a research mentor from Duke-NUS Medical School, Dr Wong has also mentored many medical students and junior colleagues in their research projects; leading to award-winning abstracts (AASLD Foundation Fellowship Award 2022, SingHealth Medical Student Talent Development Award 2022, first runner-up for oral presentation in GIHEP 2022, first and second runner-up for poster presentation in GIHep 2022) and publications in peer-reviewed journals. Dr Wong was awarded the Senior Educator Award, twice, in 2020 and 2022, for his effort in undergraduate and postgraduate medical education.

Education and Training

• Master of Clinical Investigation (MCI), Singapore, 2020
• European Specialty Examination in Gastroenterology and Hepatology, 2019
• Specialist Accreditation Board (Gastroenterology), Singapore, 2018
• MMed (Internal Medicine), Singapore, 2013
• MD, Malaysia, 2010
  

Professional Appointments and Committee Memberships

• Member, Baveno Cooperation, 2023 – Present
• Member, GLOBAL PBC Study Group, 2023 – Present 
• Fellow, Royal College of Physicians of Edinburg, 2021 – Present
• Social Media Ambassador, European Association of the Study of Liver (EASL), 2021 – Present
• Member, European Association of the Study of Liver (EASL), 2021 – Present
• Fellow, Academy of Medicine, Singapore, 2020 – Present
• Executive Committee, Gastroenterology Society of Singapore, 2021 – 2022
  

Awards

• Best Oral Presentation, GIHep Singapore, 2024
• FAMS Travel Assistance Award, Academy of Medicine, Singapore, 2024
• AASLD Foundation Fellow’s Abstract Award in Healthcare Disparity Research, 2023
• The Wong Hock Boon Society-SMA Charity Fund Outstanding Mentor Award, Singapore Medical Association, 2023
• Best Oral Presentation, CGH Research Innovation & Enterprise Day, 2023
• QI Pilot Gold award, CGH Improvement Festival, 2023
• AASLD Foundation Fellow’s Abstract Award, The Liver Meeting, 2022
• AASLD Presidential Plenary Lecture, Digestive Disease Week, 2022
• SingHealth Publish! Award, Medicine ACP, SingHealth, 2022
• Human Manpower Development Program, Singapore Ministry of Health, 2022
• 1st Runner up, Oral Presentation, GIHep Singapore, 2022
• 2nd Runner up, Oral Presentation, GIHep Singapore, 2022
• 1st Runner up, Poster Presentation, GIHep Singapore, 2022
• Senior Educator Award, Medicine Academic Clinical Programme (ACP), SingHealth, 2022
• Nurturing Clinician Research Award (NCRS), Joint Office of Academic Medicine, SingHealth, 2022
• Silver Award, CGH Improvement Festival, 2022
• Senior Educator Award, Medicine ACP, SingHealth, 2020
• MOH Healthcare Scholarship, National Medical Research Council (NMRC), 2020
• Best Oral Presentation, GIHep Singapore, 2021
• Best Oral Presentation, GIHep Singapore, 2018
• Outstanding Resident Award, Residency in SingHealth Excels (RiSE), 2018
• Outstanding Resident Award, Residency in SingHealth Excels (RiSE), 2015
• Outstanding Resident Award, Residency in SingHealth Excels (RiSE), 2013
  

Research Interests

• Improving clinical outcomes patients with liver cirrhosis
  
• Portal hypertension
  
• Viral hepatitis 
  

Research Trials

• Early detection of Hepatocellular carcinoma in a High-risk Prospective Cohort (ELEGANCE); Site-PI, 2021 - Present
• Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial; Site-PI, 2021 - Present
  

Publications

• Thomas M, Andrew M, Jonathan AC, Sherief AE, Costica A, Armstrong MJ, Pose E, Brenner E, Catana MA, Renumathy D, Ahad E, Ignacio GJ, Gill US, Jones PD, Kennedy J, Marshall A, Matthews C, Mells G, Mercer C, Perumalswami PV, Avitabile E, Qi X, Su F, Ufere NN, YJ Wong, Zheng MH, Barnes E, Barritt AS, Webb GJ. Outcome following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study. Accepted for publication in the Journal of Hepatology 2020. Doi: https://doi.org/10.1016/j.jhep.2020.09.024. (IF 25.1) 
• M Putera, Teh KB, R Kumar, YJ Wong. Small esophageal varices in compensated cirrhosis patients: to treat or not to treat? Accepted in J Hepatol [early view] (IF: 25.1)
• YJ Wong, MH Nguyen. Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with protease inhibitor-based direct-acting antiviral? Journal of Hepatology 2022, PMID: 35074472 (IF 25.1)
• CK Tan, YJ Wong, LM Wang, TL Ang, R Kumar. Autoimmune hepatitis following COVID-19 vaccination: True causality of mere association? Journal of Hepatology 2022, PMID: 8404983 (IF 25.1), 
• Miao L, Ye SM, Zheng MH; Global Chinese Fatty Liver Collaborative, Global Obesity Collaborative. "Fatty" or "steatotic": position statement from a linguistic perspective by the Chinese-speaking community. J Hepatol 2024. (early view, IF 25.1)
• Ng K, Poon BH, Puar HK, Quah LS, Loh WJ, YJ Wong, Tan TY, J Raghuram. Covid-19 and the risk of Health Care Workers: A case report. Ann Intern Med 2020. doi:10.8326/L20-0175. (Impact factor: 19.1)
• YJ Wong, M Teng, Alyssa Sim..JG Abraldes, J Chang. Full adherence to cirrhosis quality indicators is associated with a lower mortality in acute variceal bleeding: nationwide audit. Hepatology 2024 (early view). (Impact factor 14.0)
• YJ Wong, Chen VL, Abdulhamid A, et al. Comparing serial and current liver stiffness measurements to predict decompensation in compensated advanced chronic liver disease patients. Hepatology. Published online April 17, 2024. doi:10.1097/HEP.0000000000000891 (Impact factor 14.0)
• Moctezuma-Velazquez C, YJ Wong, AJ Montano-Loza. Editorial: Promise and pitfall of a natural killer cell signature for hepatocellular carcinoma detection in HCV patients with sustained virological response. Hepatology 2024 (early view). (IF: 14.0).
• Lucile Moga, Valérie Paradis, Joel Ferreira-Silva, Koushik Gudavalli, Federica Indulti, Elton Dajti, Oana Nicoara-Farcau, Giulia Tosetti, Antonina Antonenko, Andreea Fodor, Judit Vidal-González, Laura Turco, Francisco Capinha, Laure Elkrief, Teresa Monllor-Nunell, Odile Goria, Lorenz Balcar, Adrien Lannes, Vincent Mallet, Armelle Poujol-Robert, Dominique Thabut, Pauline Houssel-Debry, Yu Jun Wong, Maxime Ronot, Valérie Vilgrain, Sai Prasanth Rampally, Audrey Payancé, Laurent Castera, Thomas Reiberger, José Ferrusquía-Acosta, Carlos Noronha Ferreira, Giovanni Vitale, Macarena Simon-Talero, Bogdan Procopet, Annalisa Berzigotti, Riccardo Caccia, Fanny Turon, Filippo Schepis, Federico Ravaioli, Antonio Colecchia, Arun Valsan, Guilherme Macedo, Aurélie Plessier, Pierre-Emmanuel Rautou. Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder. Hepatology 2024 (early view) (Impact factor 14.0)
• YJ Wong, Z Chen, Tosetti G, Degasperi E, Sharma S, Agarwal S, Liu C, YH Chan, J Li, X Qi, S Anoop, Primignani M. Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients. Clin Mol Hepatol 2022. Doi: 10.3350/cmh.2022.0181 [IF: 14]
• C Liu*, H You*, QL Zeng*, YJ Wong*,..Qi X. Carvedilol to prevent hepatic decompenation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306). Clin Mol Hepatol 2024 July. [IF 14.0]
• C Liu*, Z Cao*, H Yan*, YJ Wong*, Q Xie*, H Masashi*, Hirayuki E*, TH Kim*, AS Hanafy*, Y Liu, YF Huang, X Li, N Kang, K Yohei, H Yoichi, N Takashi, I Hiroko, YK Jung, HJ Yim, G Ying, L Zhang, JMa, M Kumar, J Ankur, KB The, S Sarin, Xiaolong Qi. A novel SAVE score to stratify decompensation risk in compensated advanced chronic liver disease: an international multicenter cohort study. American Journal of Gastroenterology June 15 2022, doi: 10.14309/ajg.00000000001873 [IF 10.3]
• E Quek, JH Loo, EQ Lim, A Chung, AB Othman, J Tan, S Barnett, M Nguyen, YJ Wong. Global Epidemiology, Natural History, Maternal-to-child transmission, and treatment with DAA of Pregnant women with HCV: A systematic review and meta-analysis. Accepted in eClinicalMedicine [IF 9.6]
• Chuan Liu*, Li jia*, YJ Wong*, Qing Xie*, Masahi Hirooka*, Hirayuki Enomoto*, Tae Hyung Kim, Amr Shaaban Hanafy, Ruiling HE, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Young Kul Jung, Hyung Joon Yim, Jianzhong Ma, Qing-Lei Zeng, Shiv Kumar Sarin, Qi Xiaolong. ABC: a novel algorihm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study. Accepted in Hepatology International (IF 9.046) *co-first author
• YJ Wong, S Tran, Huang CF et al. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study. Hepatol Int 2023. (IF: 7.1)
• Bai Z, Méndez-Sánchez N, Romeiro FG, Mancuso A, Philips CA, Tacke F, Basaranoglu M, Primignani M, Ibrahim M, Wong YJ, Nery FG, Teschke R, Ferreira CN, Muñoz AE, Pinyopornpanish K, Thevenot T, Singh SP, Mohanty A, Satapathy SK, Ridola L, Maruyama H, Cholongitas E, Levi Sandri GB, Yang L, Shalimar, Yang Y, Villa E, Krag A, Wong F, Jalan R, O'Brien A, Bernardi M, Qi X; Liver Cirrhosis-related Complications (LCC)-International Special Interest Group. Use of albumin infusion for cirrhosis-related complications: An international position statement. JHEP Rep. 2023 May 5;5(8):100785. doi: 10.1016/j.jhepr.2023.100785. PMID: 37456673 (IF: 8.3)
• ZY Lee, CH Charles Lew, OR Alfonso, JJ Patel, YJ Wong, TI Loh, RG Martindale, DK Heyland. Benefits and harm of probiotics and synbiotics in adult critically ill patients. A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. Accepted in Clinical Nutrition [early view 2023] (IF: 8.23)
• Sun, D., Targher, G., Byrne, C., Wheeler, D., Wong, V., Fan, J., Tilg, H., Yuan, W., Wanner, C., Gao, X., Long, M., Kanbay, M., Nguyen, M., Navaneethan, S., Yilmaz, Y., Huang, Y., Gani, R., Marzuillo, P., Boursier, J., Zhang, H., Jung, C., Chai, J., Valenti, L., Papatheodoridis, G., Musso, G., YJ Wong., El-Kassas, M., Méndez-Sánchez, N., Sookoian, S., Pavlides, M., Duseja, A., Holleboom, A., Shi, J., Chan, W., Fouad, Y., Yang, J., Treeprasertsuk, S., Cortez-Pinto, H., Hamaguchi, M., Romero-Gomez, M., Al Mahtab, M., Ocama, P., Nakajima, A., Dai, C., Eslam, M., Wei, L., George, J., & Zheng, M. (2023). An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease. Hepatobiliary Surgery And Nutrition, 2023. doi:10.21037/hbsn-22-421 (IF: 8.265)
• B Choo, GBB Goh, SY Chia, HC Oh, NC Tan, Jessica Tan, TL Ang, YM Bee, YJ Wong. Non-alcoholic fatty liver disease in type-II Diabetes Mellitus: A cost-effectiveness and price-threshold analysis. Accepted in Annals of Academy of Medicine Singapore 2022. (IF 8.713)
• YJ Wong, PH Thurairajah, R Kumar, Fock KM, NM Law, Sy Chong, FG Manejero, Ang TL, Teo EK, J Tan. The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients. Accepted in Clinical Molecular Hepatology [IF 8.33]
• YJ Wong, Rahul Kumar. Follow-up paracentesis in spontaneous bacterial peritonitis: prognostic, but may not improve survival. Accepted in press in Clinical Gastroenterol Hepatol 2021. (IF: 11.38)
• YJ Wong. Editorial: an elastography-based two-step approach to detect NAFLD with compensated advanced chronic liver disease. Aliment Pharmacol Ther 2021; 54: 515-516. IF: 8.17
• YJ Wong, Juan G Abraldes. Editorial: Shorter course of intravenous Terlipressin in acute variceal bleeding – the promise, controversies, and future directions. Aliment Pharmacol Ther 2024; 59(7): 889-890. IF: 8.17
• Daphne Ang, Seok Hwee Koo, Yiong Huak Chan, Thean Yen Tan, Gaik Hong Soon, Chin Kimg Tan, Kenneth Weicong Lin, Jaydeesh-Khanna Krishnmasamy-Balasubramaniam, YJ Wong, Rahul Kumar, Rajesh R, Yiyuan Tan, Jeannie Ong, Jessica Tan, James Li, Andrew Kwek, Tiing Leong Ang. Clinical trial: seven-day vonoprazan versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication. Alimentary Pharmacology and Therapiutics 2022. Httpw://doi.orh/10.1111/apt.17070 (IF 8.17)
• YJ Wong, N Singh, N Sanchez-Fernandez, AJ Montano-Loza. Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology. Hepatobiliary Surg Nutr 2024 [early view] (IF: 8.265)
• D Sun; G Targher; CD Byrne; DC Wheeler; Vincent Wong; JG Fan; H Tilg; WJ Yuan; C Wanner; X Gao; MT Long; M Kanbay; Mindie H Nguyen; JM Schattenberg; SD Navaneethan; Yusuf Yilmaz; YHuang; RA Gani; PMarzuillo; J Boursier; H Zhang; CY Jung; J Chai; L Valenti; G Papatheodoridis; G Musso; YJ Wong; M El-Kassas; N Méndez-Sánchez; S Sookoian; M Pavlides; A Duseja; AG Holleboom; JP Shi; WK Chan; YF Fouad; J Yang; S Treeprasertsuk; HCortez-Pinto; M Hamaguchi; M Romero-Gomez; MA Mahtab; H Hagström; P Ocama; A Nakajima; C Dai; M Eslam; L Wei; J George; Ming-Hua Zheng. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of CKD. Accepted for publication in Hepatobiliary Surg Nutr 2023 [early view] (IF: 8.265)
• Yifei Huang, Li JiA, Tianlei Zheng, Dong JI, YJ Wong, Hong You, Ye Gu, Li M< Zhao L, Li S, Geng S, Yang N, Chen G, Wang Yan, Kumar M, Jindal A, Qin W, Chen Z, Xin Y, Jiang Z, Chi X, Cheng J, Zhang M, Liu H, Lu M, Li L, Zhang Y, Pu C, Ma D, He Q, Tang S, Wang C, Liu S, Wang UJ, Liu Y, Liu C, Liu H, Shiv Kumar Sarin, Qi Xiaolong. Development and validation of a machine learning-based model for varices screening in compensated cirrhosis (CHESS2001): An international multicenter study. Gastrointest Endosc 2022; doi: https://doi.org/10.1016/j.gie.2022.10.018 (IF: 10.396)
• YJ Wong, Chew SY, Hsiang JC, Thurairajah PH, Kumar R, Teo EK, Gokhale RS, Noor IBM, Tan J. (2018). VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature. Clin Mol Hepatol 2018. doi: 10.3350/cmh.2018.0017 (Impact Factor: 8.33)
• YJ Wong. Letter: Baveno-VI criteria to exclude large varices in patients with hepatocellular carcinoma – what have we learned? Aliment Pharmacol Ther 2023 [early view], IF: 7.6
• JW E Quek, JH Loo, A Jaroenlpnopparat, C Jimenez, M A-karaghouli, V Vargas, JP Arab, JG Abraldes, YJ Wong. Prophylactic antibiotics in patients with alcohol-associated hepatitis receiving steroids: A systematic review and meta-analysis. Accepted in Liver International 2024 (IF: 6.7)
• M Putera, CK Tan, YJ Wong, R Kumar. Higher mortality in acute variceal hemorrhage: Is fresh frozen plasma alone to be blame? Liv Int 2021 [early view] (IF: 5.8)
• YJ Wong, E Urias, M Song et al. Combination of Fibrosis-4, liver-stiffness measurement, and Fibrosis-AST score to predict liver-related outcomes in nonalcoholic fatty liver disease. Hepatol Commun 2023;7(10):e0244 (IF: 5.7)
• A Mohammad, S Sung, Wayne Bai, Matthew Tan, YJ Wong, C Jordi, Cobo Erik, GA Jose Antonio, Juan G Abraldes. Heterogeneity of treatment response to beta-blocker in the treatment of portal hypertension: a systematic review. Accepted in Hepatol Commun 2023. (IF: 5.7)         
• Al-Karaghouli M, Ventura-Cots-M, YJ Wong et al. Relationship between updated MELD and prognosis in alcohol-associated hepatitis:opportunities for more efficient trial design. Accepted in Hepatol Commun 2024. (IF: 5.7)
• YJ Wong, MH Nguyen. Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with protease inhibitor-based direct-acting antiviral? Liver International 2022, PMID: 35220647 (IF 5.8)
• P Devan, KLA Tiong, JE Neo, B Mohan, K Wijarnpreeecha, YC Tam, N Copolla, C Preda, YJ Wong. Treatment outcomes of Sofosvubir/Velpatasvir/Voxilaprevir in Direct-acting antiviral-experienced hepatitis C patients: A systematic review and meta-analysis. Viruses 2023; 15)7): 1489. IF: 5.8
• YJ Wong, JG Abraldes. Pharmacological treatment for portal hypertension. Clinics in Liver Disease 2024 (IF 5.1)
• YJ Wong, Irani FG, Tan M, Teo M (2018). Massive upper gastrointestinal bleeding post-Whipple from anastomotic varices due to mesenteric hypertension. Endoscopy 50(7):E159-E162. doi: 10.1055/a-0595-7507 [Impact Factor: 5.196]
• YJ Wong, DWL Ho, JG Abraldes. Pre-emptive TIPSS in acute variceal bleeding: current status, controversies and the direction forward. Accepted in Journal of Clinical and Translational Hepatology 2022 [IF 5.065]
• YJ Wong, Teh JGX, Khor C, Tan DMY. Endoscopic ultrasound-guided choledochoduodenostomy and duodenal stenting for combined malignant biliary and duodenal obstruction. Endoscopy (early view) 2019. IF 5.196
• Xu W, Bai Z, Shang Y, YJ Wong, Qi X. Incidence and types of adverse events in patients taking vonoprazan: A systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2023 [early view] (IF: 4.85)
• YJ Wong, Jia Li, Chuan Liu, Zhaojin Chen, Yiong Huak Chan, Martin Putera, Kok Ban Teh, Tiing Leong Ang, Lili Zhao, Zhongyang Yan, Rahul Kumar, Xin LI, Xiaolong Qi. CHES-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: an international multicenter study. Journal of Gastroenterology & Hepatology 2022, PMID: 35253271 [IF 4.0]
• YJ Wong, PH Thurairajah, R Kumar, J Tan, Fock KM, Law NM, Li JW, A Kwek, Tan YB, Koh Y, Lee ZC, LS Kumar, Teo EK, Ang TL. Efficacy and safety of sofosbuvir/velpatasvir in a real world chronic hepatitis C genotype 3 cohort. Accepted in Journal of Gastroenterology & Hepatology (IF 4.0)
• YJ Wong, Jia Li, Chuan Liu, Zhaojin Chen, Yiong Huak Chan, Martin Putera, Kok Ban Teh, Tiing Leong Ang, Lili Zhao, Zhongyang Yan, Rahul Kumar, Xin LI, Xiaolong Qi. CHES-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: an international multicenter study. Journal of Gastroenterology & Hepatology 2022, PMID: 35253271 (IF 4.0)
• YJ Wong, Jia Li, Zhaojin Chen, Liu Chuan, Xiaolong Qi. Reply: CHESS-ALARM score: Can it raised the alarm accurately? Accepted in Journal of Gastroenterology & Hepatology 2022 [early view] (IF 4.1)
• YJ Wong, Zhaojin Chen, Jia Li, Chuan Liu, Xiaolong Qi, Chan Yong Huak. Reply: CHESS-ALARM score: is it a 5-year prediction score? Accepted in Journal of Gastroenterology & Hepatology 2022 [early view] (IF 4.1)
• Hussain I, YJ Wong, L Rahul. L Su, R Kumar. Does pre-emptive TIPSS improve survival after acute variceal bleeding? Systematic review, meta-analysis and trial-sequence analysis of randomized trial. Accepted in Journal of Gastroenterology & Hepatology 2021 (IF 4)
• JH Koh, ZH Liew, Gin Kee NG, Hui Ting Liu, Yew Chong Tam, AD Gottardi, YJ Wong. Efficacy and safety of direct oral anticoagulant versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis. Accepted in Digestive and Liver Disease 2021 (IF 4.09)
• Li Weiquan, T Chia, DW Chong, YJ Wong, Tiing Leong Ang. Artificial intelligence and polyp detection in colonoscopy: use of a single neural network to achieve rapid polyp localization for clinical use. Accepted for publication in Journal of Gastroenterology & Hepatology 2021 (IF 4)
• YJ Wong, JH Loh, DMY Tan (2019). Gastrointestinal: An uncommon case of severe esophagitis. J Gastroenterol Hepatol; 34(1): 7 (Impact Factor: 4.0)
• YJ Wong, Qiu TY, Tam TY, M Babu, D Adler. Efficacy and safety for IV albumin for non-spontaneous bacterial peritonitis infection among patients with cirrhosis: A systematic review and meta-analysis. Digestive and Liver Disease. IF:  4.01
• Ang TL, YJ Wong. Endohepatology: more progress but not yet ready for prime time. Accepted in Journal of Gastroenterology & Hepatology 2022 [early view] (IF 4.1) Doi: 10.1111/jgh.15914
• Zheng X, Bai Z, T Wang, Romeiro FG, A Mancuso, CA Phillips, YJ Wong, FG Nery, X Qi. 
• Human albumin infusion for the management of liver cirrhosis and its complications: an overview of major findings from meta-analysis. Accepted in Adv Ther 2023, doi: 10.1007/s12325-023-02430-3 (IF: 3.4)
• Loo JH, Xu FWX, Low TJ, Tay WX, Ang LS, Tam YC, PH Thurairajah, R Kumar, YJ Wong. Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: a meta-analysis. World J Hepatol 2022; 14 (6): 1248-1257; Doi: https://dx.doi.org/10.4254/wjh.v14.i6.1248 [IF 3.17]
• Chang PE, Tan CK, Cheah CC, Li W, Chow WC, YJ Wong. Validation of the expanded Baveno-VI criteria for screening gastroscopy in Asian with compensated advance chronic liver disease. Accepted for publication in Digestive Disease and Sciences. IF: 2.94
• Z Wong, Jia Hong Koh, ..YJ Wong ..Cheng Han Ng Margaret Teng. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A meta-analysis. Digestive Disease and Science, 2023 (IF: 3.0)
• Huang YW, Seah JJ, Tan CK, C Kam, J Tan, Teo EK, A Kwek, YJ Wong, M Tan, Ang TL, R Kumar. Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with Non-alcoholic Fatty liver disease. Accepted for publication in Clinics and Research in Hepatology and Gastroenterology. IF: 2.718
• YJ Wong, Kumar R, Chua YJJ, Ang TL. Long-term albumin infusion in decompensated cirrhosis: A review of current literature. World J Hepatol. 2021 Apr 27;13(4):421-432. doi: 10.4254/wjh.v13.i4.421. PMID: 33959225; (IF: 2.77)
• G Kang, LS Ang, WH Leia Teo, YW Huang, V Narayan, BE Kwek, TL Ang, YJ Wong. Clinical outcomes of variceal and non-variceal upper gastrointestinal bleeding in patients with liver cirrhosis. Singapore Med J 2023 [early view]
• Lee ZY, Suah BH, Teo YH,.. YJ Wong..Sia SC et al. Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation and Concomitant Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am J Cardiovasc Drugs. 2021;10.1007/s40256-021-00482-w. (IF: 2.67)
• Jing Hong Loo, YJ Wong. Albumin therapy for hepatic encephalopathy: current evidence and controversies. Accepted in Metabolic Brain Disease 2022 (IF: 2.63)
• Teh KB, Loo JH, Tam YC, YJ Wong. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis. Dig Liver Dis. 2021 May 16:S1590-8658(21)00215-2. PMID: 34011479. (OIF: 2.37)
• YJ Wong, CK Tan, Yii YL et al. Antibiotic prophylaxis in cirrhosis patients with upper gastrointestinal bleeding: an updated systematic review and meta-analysis. Port Hypertens Cirrhos 2022; 1: 167-177
• YJ Wong, M Tan, Q Zheng, Li WQ, R Kumar, Fock KM, Teo EK, Ang TL. A systematic review and metaanalysis of the COVID-19 associated liver injury. Accepted for publication in Annals of Hepatology. IF: 2.12
• A Ahmed, S Sharma, S Agarwal, YJ Wong, M Putera, Anoop Saraya. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis. Ind J Gatsroenterol 2023 (early view)
• Ji F, Tran S, Ogawa E, Huang CF, Suzuki T, Wong YJ..MH Nguyen et al. Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study. J Clin Transl Hepatol. (IF 5.1)
• Teh KJ, Tay SW, Chen KN, Koh J S, YJ Wong, Kwek BE, Li W, Fock KM, Teo EK, Ang TL, Tan TK. Impact of enchanced personal protective equipment on colonoscopy performance during the COVID-19 pandemic. Endoscopy International Open 2020. 
• Ang TL, J Li, YJ Wong, J Tan, Fock KM, Tan TMM, Kwek BEA, Teo EK, Ang SW, Wang LM. A prospective randomized study of colonoscopy using blue laser imaging and white light imaging in detection of colonic polyps. Endoscopy Open 2019;-7:E1207-1213. 
• YJ Wong, Lum HM, Fook SC, Lim ST, Salazar E. Gastrointestinal tract lymphoma receiving chemotherapy: Does prophylactic total parenteral nutrition and bowel rest reduce the risk of perforation? Nutrition 2020 (IF: 3.42) DOI: https://doi.org/10.1016/j.nut.201903.023 
• YJ Wong (2018). Cytomegalovirus infection in an immunocompetent patient. Gastrointest Endosc 88(6): 969-970. (Impact Factor: 7.204)
• Tan YY, SKG Tay, YJ Wong, JW Li, BE Kwek, TL Ang, LM Wang, TK Tan. Clinical features and predictors of dysplasia in proximal sessile serrated lesions. Clin Endosc 2021 [early view] (IF: 1.8)
• G Kang, LS Ang, WHL Teo, V Narayan, A Kwek, TL Ang, YJ Wong. Clinical outcomes of variceal and non-variceal upper gastrointestinal bleeding in patients with cirrhosis in Singapore. Accepted for publication in Singapore Medical Journal 2023 
• Chang PE, YJ Wong, Yang WL et al. Recommendations and guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic. Accepted for publication in Singapore Medical Journal. IF: 1.14
• YJ Wong, Lum HM, Tan PT, Teo EK, Jessica Tan, PH Thurairajah. Clinical implications of prompt ascitic drain removal among cirrhosis with refractory ascites. Accepted for publication in Singapore Medical Journal. IF: 1.14 
• YJ Wong, R Kumar, Jessica Tan, PT Thurairajah. Author's reply: Comment on: Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites. Singapore Medical Journal 2021; 62 (12): 666 (IF: 1.08)
• YJ Wong, K Rajamanickam, K Lin, J Tan, EK Teo, J Li, Ang TL (2019). Short-term and long-term predictors for spontaneous bacterial peritonitis in Singapore. Accepted for publication in Singapore Medical Journal (Impact Factor: 1.08)
• TL Ang, KW Lim, Daphne Ang, YJ Wong, M Tan, SYA Wong. Clinical audit of current Helicobacter pylori treatment outcomes in Singapore. Accepted in Singapore Med J 2021 (IF: 1.14)
• Lee ZC, YJ Wong, Ti LL et al. Hashimoto's thyroiditis-related myopathy in a patient with SARS-CoV-s infection: A case report and systematic literature review. Medicine 2023; 102(42): e35720. Impact factor 1.8
• R Rana, S Sharma, S Ahmed, A Gupta, YJ Wong, D Gunjan, S Anoop. Evaluating the practice of prescribing beta-blocker in compensated cirrhosis by gastroenterologists in the Asia Pacific region. Clinical and Experimental Hepatology 2022 Sept 20. Doi: heeps://doi.org/10.1016/j.ceh.2022.09.003
• YJ Wong, Cheen M, Hsiang JC, Kumar R, Tan J, Teo EK, Thurairajah PH (2018). Economic evaluation of direct-acting antiviral for the treatment of Genotype 3 Hepatitis C infection in Singapore. JGH Open. doi:10.1002/jgh3.12139 
• SM Alhamid, DX Lee, HM Wong, MB Chuah, YJ Wong, K Narasimhalu, TT Tan, SY Low (2016). Implementing electronic handover: interventions to improve efficiency, safety and sustainability. Int J Qual Health Care; 28(5): 608-614 (Impact Factor: 2.554)
• YJ Wong, Choo KJL, Soh JXJ, Tan CK (2018). Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilic and systemic symptoms. Singapore Med J; 59(1): 112-113. doi: 10.11622/smedj.2018016 (Impact Factor: 1.08)
• YJ Wong, Choo KJL, Soh JXJ, Tan CK (2018). Author's reply: Comment on: Cytomegalovirus (CMV) hepatitis: an uncommon complication of CMV reactivation in drug reaction with eosinophilic and systemic symptoms. Singapore Med J; 59(5): 289-290 (Impact Factor: 1.08)
• Hassam Ali, Vishali M, Deepa B, Ritika O, P Patel, YJ Wong, Eduardo RA, B Mohan. A propensity matched analysis of performing versus not performing renal replacement therapy prior to liver transplant in end stage liver disease patients without concomitant kidney disease. JGH Open 2024; 8(1): e13028. 
• Zheng Cong Lee, YJ Wong, LL Ti..A Santosa. Hashimoto's thyroiditis-related myopathy in a patient with SARS-CoV-2 infection: A case report and systematic literature review. Medicine 2023; 102(42): e35720
• Qiu TY, See JJ, Shi HY, YJ Wong. Acute liver failure and seizure: a case report of an unusual presentation of acute painless aortic dissection. Accepted for publication in European Heart Journal – Case report 2020. 
• YJ Wong, Tan BH, Leow WQ, SJ Mesenas (2018). Cytomegalovirus masquerading as gastric cancer in an immunocompromised host. Proceedings of Singapore Healthcare 27(1): 63-66. doi:10.1177/2010105817731797
• YJ Wong, Eng HK, Lath N, Namasivayam V (2018). Clinical features of paraduodenal hernia. Proceedings of Singapore Healthcare 27(2): 139-142.
• YJ Wong, Tan BX, Chlebicki MP, Schwender BJ (2017). Abiotrophia defectiva: A rare gut pathogen resulting endocarditis in inflammatory bowel disease. Journal of Microbiology and Infectious Disease 7(4): 217-219. doi:10.5799/jmid.369281